In the final episode of the Myeloma Series, Manni Mohyuddin, MD, discusses multiple myeloma treatment as an art where clinicians take imperfect data to try to make the best decisions for patients. He also discusses his approach to transplant and bridging strategies, the use of agents like venetoclax and the role of chimeric antigen receptor therapy.